AIP and acromegaly: Also, AIP low expression tumors may be pasireotide-responsive, indicating that this pathway is not exclusively implicated in the biological response to pasireotide, in opposition to what happens with first-generation SRLs, in which it plays an important role; this has been recently described in AIP mutated acromegaly patients (84).